Compare · EYE vs RXST
EYE vs RXST
Side-by-side comparison of National Vision Holdings Inc. (EYE) and RxSight Inc. (RXST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EYE and RXST operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- EYE is the larger of the two at $1.55B, about 7.4x RXST ($209.5M).
- Over the past year, EYE is down 20.9% and RXST is down 34.8% - EYE leads by 13.8 points.
- EYE has been more active in the news (10 items in the past 4 weeks vs 4 for RXST).
- RXST has more recent analyst coverage (25 ratings vs 20 for EYE).
- Company
- National Vision Holdings Inc.
- RxSight Inc.
- Price
- $19.75+2.36%
- $5.05-0.39%
- Market cap
- $1.55B
- $209.5M
- 1M return
- +8.31%
- +5.21%
- 1Y return
- -20.95%
- -34.75%
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2017
- 2021
- News (4w)
- 10
- 4
- Recent ratings
- 20
- 25
National Vision Holdings Inc.
National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. As of January 2, 2021, the company operated through 1,205 retail stores, as well as various e-commerce websites. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.
RxSight Inc.
RxSight, Inc., a medical technology company, develops light adjustable lens (LAL) to improve uncorrected visual acuity that can be adjusted enhance uncorrected visual acuity after cataract surgery. It also offers RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is based in Aliso Viejo, California.
Latest EYE
- President, America's Best Banner Mark converted options into 11,728 shares and covered exercise/tax liability with 4,964 shares, increasing direct ownership by 38% to 24,603 units (SEC Form 4)
- Director Zulla Caitlin was granted 16,258 shares, increasing direct ownership by 74% to 38,138 units (SEC Form 4)
- Director Ofarrell Susan C was granted 14,571 shares, increasing direct ownership by 65% to 36,904 units (SEC Form 4)
- Director Nicholson Michael J was granted 11,350 shares, increasing direct ownership by 106% to 22,069 units (SEC Form 4)
- Director Mcgrann James M. was granted 11,350 shares, increasing direct ownership by 106% to 22,069 units (SEC Form 4)
- Director Johnson Susan S was granted 11,350 shares, increasing direct ownership by 26% to 55,050 units (SEC Form 4)
- Director Kelman Naomi was granted 11,350 shares, increasing direct ownership by 28% to 52,391 units (SEC Form 4)
- Director Hepner Virginia A was granted 11,350 shares, increasing direct ownership by 26% to 55,377 units (SEC Form 4)
- Director Armario Jose was granted 16,258 shares, increasing direct ownership by 33% to 66,159 units (SEC Form 4)
- National Vision Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
Latest RXST
- RxSight Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- RxSight Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
- RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement
- Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
- Director Warner Robert Keith was granted 37,037 shares, increasing direct ownership by 90% to 78,076 units (SEC Form 4)
- Director Palmisano Robert J was granted 37,037 shares, increasing direct ownership by 90% to 78,076 units (SEC Form 4)
- Director Maniar Shweta was granted 37,037 shares, increasing direct ownership by 204% to 55,172 units (SEC Form 4)
- Director Fountain Tamara was granted 37,037 shares, increasing direct ownership by 104% to 72,582 units (SEC Form 4)
- Director Link William J Phd was granted 37,037 shares, increasing direct ownership by 98% to 74,892 units (SEC Form 4)
- Director Corley Jesse Anderson was granted 37,037 shares, increasing direct ownership by 75% to 86,227 units (SEC Form 4)